Espoo, Finland, December 2022. Euformatics, a global leader in NGS data quality control and variant interpretation, together with Finland’s BC
HELSINKI, Finland, September 2022. Euformatics, a Finnish company providing services for NGS variant interpretation and quality control, had
ESPOO, Finland, July 1st 2022. Finnish IT company Euformatics has been awarded a grant from the European Commission’s Recovery and Resilience
HELSINKI, Finland May 2022. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized
Go to recorded webinar. Next Generation Sequencing (NGS) relies on several quite distinct steps, all with potential effect on the patient
The omnomicsNGS variant interpretation tool for annotation, classification and reporting has been upgraded to its latest version 2.7 this week in an
HELSINKI, Finland, April 2022. Viafet Genomics Laboratory, a leading laboratory in the field of human genetics in The United Arab Emirates has